REGISTERED NUMBER: 10566270 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

UROLOGY SOLUTIONS CARDIFF LIMITED

Page

Balance sheet

1

FIXED ASSETS

21

85

CURRENT ASSETS

37,973

37,007

CREDITORS

Amounts falling due within one year

(23,980

)

(22,754

)

NET CURRENT ASSETS

13,993

14,253

TOTAL ASSETS LESS CURRENT LIABILITIES

14,014

14,338

CAPITAL AND RESERVES

14,014

14,338

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Urology Solutions Cardiff Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10566270

Registered office:

22 Cefn Onn Meadows

Lisvane

Cardiff

CF14 0FL

The presentation currency of the financial statements is Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2024 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 14 October 2025 and were signed on its behalf by:

Dr S Datta - Director